The curious case of Onpattro, siRNA in lipid nanoparticle now being considered by some as a potential treatment for mRNA injuries
I had a friend in school, who needed a “pre-dinner” before dinner, and then a pizza slice after the dinner. He was skinny. I still hate him.
This is not a hit piece. This is a “pre-crime” novel.
Due Diligence and Art is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.
Upgrade to paid
A couple of weeks ago, many of us were rather shocked by the following publication:
Courageous Discourse™ with Dr. Peter McCullough & John Leake
17 days ago · 185 likes · 30 comments · Peter A. McCullough, MD, MPH
In their review paper, Huschler, McCullough and Marotta proposed that treatment of mRNA induced vaccine injury may be mitigated with small interfering RNA (siRNA) and ribonuclease targeting chimeras (RIBOTACs). Quoting from the Substack post by Dr. McCullough:
It may seem unfathomable for doctors to inject more RNA to deactivate Pfizer and Moderna synthetic mRNA that has accumulated in the body after multiple injections. However, siRNA used today in my practice (patisiran, inclisiran) appears to be safe and well-tolerated only notable for injection site reactions.
I am one of the people for whom this idea is unfathomable, and I would like to provide some reasons as to why. I am not accusing anyone of anything. I believe that there is important information missing from this review, which I am going to discuss here.
While proposing siRNA as a treatment for mRNA injury, the paper does not discuss the current on-market siRNA drugs (patisiran – Onpattro, and inclisiran- Leqvio) in detail.
To address Leqvio briefly: it is administered by subcutaneous injection that targets the liver, has many severe counterindications, is known to cause fetal damage, has warnings for cardiovascular adverse events (while being indicated to presumably improve cardiac condition!), and it has never been shown to improve any real health outcomes. As many “new-new-science” drugs on the market, it treats test results, flowcharts, “standards of care” and income statements, not real humans. It is designed to “modify lipids”, i.e. make your cholesterol test look better in the eyes of the establishment/government medicine. The label states that “the effect of inclisiran on cardiovascular morbidity and mortality has not yet been determined”.
This article will focus on Onpattro, as it is similar to the covid shots, being a synthetic RNA (albeit a much smaller strand vs mRNA), encapsulated in LNP containing polyethylene glycol (PEG) – a known extremely toxic substance, which may account for a large % of known covid jab toxicities.
Onpattro (patisiran) is an injectable small interfering RNA that may be used to treat polyneuropathy (multiple nerve damage) caused by hereditary transthyretin-mediated amyloidosis (ATTR) in adults. ATTR occurs when liver produces faulty transthyretin (TTR) proteins and TTR deposits accumulate in organs and tissues, most commonly the peripheral nerves. While I have not delved into ATTR, when exactly it was discovered and what evidence makes it hereditary, I strongly suspect that it is yet another BS new “rare genetic disease” made up as a cover for vaccine and/or environmental toxicity.
New Human New Earth Communities 